Danaher Corporation (LON:0R2B)
224.67
+0.15 (0.07%)
At close: Dec 19, 2025
Danaher Revenue
Danaher had revenue of $6.05B USD in the quarter ending September 26, 2025, with 4.40% growth. This brings the company's revenue in the last twelve months to $24.27B, up 2.22% year-over-year. In the year 2024, Danaher had annual revenue of $23.88B, down -0.06%.
Revenue (ttm)
$24.27B
Revenue Growth
+2.22%
P/S Ratio
6.56
Revenue / Employee
$385.21K
Employees
63,000
Market Cap
118.75B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 23.88B | -15.00M | -0.06% |
| Dec 31, 2023 | 23.89B | -2.75B | -10.33% |
| Dec 31, 2022 | 26.64B | 1.84B | 7.42% |
| Dec 31, 2021 | 24.80B | 2.52B | 11.30% |
| Dec 31, 2020 | 22.28B | 4.37B | 24.42% |
| Dec 31, 2019 | 17.91B | 862.00M | 5.06% |
| Dec 31, 2018 | 17.05B | 1.53B | 9.86% |
| Dec 31, 2017 | 15.52B | -1.36B | -8.08% |
| Dec 31, 2016 | 16.88B | 2.45B | 16.97% |
| Dec 31, 2015 | 14.43B | 1.57B | 12.18% |
| Dec 31, 2014 | 12.87B | -5.42B | -29.62% |
| Dec 31, 2013 | 18.28B | 22.70M | 0.12% |
| Dec 31, 2012 | 18.26B | 2.17B | 13.49% |
| Dec 31, 2011 | 16.09B | 3.54B | 28.21% |
| Dec 31, 2010 | 12.55B | 2.03B | 19.33% |
| Dec 31, 2009 | 10.52B | -2.18B | -17.17% |
| Dec 31, 2008 | 12.70B | 1.67B | 15.16% |
| Dec 31, 2007 | 11.03B | 1.56B | 16.48% |
| Dec 31, 2006 | 9.47B | 1.59B | 20.26% |
| Dec 31, 2005 | 7.87B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.24B |
| GSK plc | 32.17B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| Convatec Group | 1.72B |
| Genus | 672.80M |
| HUTCHMED (China) | 439.54M |
Danaher News
- 5 days ago - Why Wall Street and Jim Cramer think Danaher stock is 'ready to go for a romp' - CNBC
- 5 days ago - Wells Fargo Adjusts Price Target for Danaher (DHR) to $240 | DHR Stock News - GuruFocus
- 8 days ago - How Do Investors Really Feel About Danaher Corp? - Benzinga
- 9 days ago - VV, BSX, DHR, SYK: ETF Outflow Alert - Nasdaq
- 10 days ago - Here's How Much $1000 Invested In Danaher 10 Years Ago Would Be Worth Today - Benzinga
- 10 days ago - Danaher: Biotech Strength And Cash Generation Reinforce A $250 Fair Value - Seeking Alpha
- 11 days ago - Danaher declares $0.32 dividend - Seeking Alpha
- 11 days ago - Danaher Announces Quarterly Dividend - PRNewsWire